IL-15-IN-1

CAS No. 1831830-20-6

IL-15-IN-1( —— )

Catalog No. M23831 CAS No. 1831830-20-6

IL-15-IN-1 is a selective?and potent Interleukin 15 (IL-15) inhibitor, inhibiting the proliferation of IL-15-dependent cells (IC50: 0.8 μM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 174 In Stock
5MG 260 In Stock
10MG 410 In Stock
25MG 678 In Stock
50MG 954 In Stock
100MG 1287 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    IL-15-IN-1
  • Note
    Research use only, not for human use.
  • Brief Description
    IL-15-IN-1 is a selective?and potent Interleukin 15 (IL-15) inhibitor, inhibiting the proliferation of IL-15-dependent cells (IC50: 0.8 μM).
  • Description
    IL-15-IN-1 is a selective?and potent Interleukin 15 (IL-15) inhibitor, inhibiting the proliferation of IL-15-dependent cells (IC50: 0.8 μM).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Apoptosis
  • Target
    IL Receptor
  • Recptor
    IL-15
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1831830-20-6
  • Formula Weight
    576.71
  • Molecular Formula
    C30H36N6O4S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:122 mg/mL (211.55 mM; Need ultrasonic)
  • SMILES
    O=C(OCC)C1=CC=CC(NC(CCCCCCCSC2=NN=C(CC3=NN(C)C(C4=C3C=CC=C4)=O)N2C)=O)=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Quéméner A, et al. Discovery of a Small-Molecule Inhibitor of Interleukin 15: Pharmacophore-Based Virtual Screening and Hit Optimization. J Med Chem. 2017 Jul 27;60(14):6249-6272.
molnova catalog
related products
  • Vunakizumab

    Vunakizumab (Anti-Human IL17A Recombinant Antibody) is a human IgGκ monoclonal antibody that specifically targets and inhibits IL-17A's receptor interaction, making it useful for researching autoimmune conditions such as psoriatic arthritis, ankylosing spondylitis, multiple sclerosis, and inflammatory arthritis .

  • Tocilizumab

    Tocilizumab anti-IL-6R) is a humanized monoclonal antibody that binds to the interleukin-6 receptor.

  • Taraxasterol

    Taraxasterol is compound with anti-inflammatory activity.